#United States #Las Vegas #MCG Health #Telligen #HLTH 2026

MCG and Telligen Present AI-Enabled Advances in Healthcare

As the healthcare landscape continues to evolve, the integration of artificial intelligence (AI) into medical decision-making processes is gaining traction. One notable event that will highlight this trend is the HLTH 2026 conference, taking place from November 15 to 18 at the Venetian Expo Center in Las Vegas, Nevada. MCG Health, a key player in clinical guidance, alongside Telligen, known for its population health management capabilities, will showcase their pioneering work in AI-enabled medical necessity reviews.

Focus on Evidence-Based Approaches

The session titled "Smarter Medical Necessity Review with AI" will feature insights from Daniel Cawood, Senior Manager of Product Management at MCG, and Nancy Johnson, Senior Manager of Quality Improvement at Telligen. Their presentation will illuminate the benefits of leveraging AI-driven tools in improving utilization management while adhering to evidence-based clinical guidelines.

In a landscape where timely and transparent decision-making is of utmost importance, Cawood and Johnson will share concrete examples from real-world applications. According to Cawood, this session will be critical for healthcare professionals looking to streamline their processes: "Attendees will learn how AI can enhance the efficiency of medical necessity reviews while keeping decisions firmly based on nationally recognized guidelines. A transparent framework for these reviews is essential for fostering clinical rigor."

Transformative Insights from Telligen

Telligen's experience with AI-enhanced medical necessity reviews is particularly noteworthy. Johnson explains, "AI-tools have allowed us to significantly reduce review timelines without sacrificing the quality and integrity of clinical decisions. By integrating MCG's evidence-based guidelines with our innovative solutions, we can dedicate more time to complex cases, ensuring that all decisions made are defensible and aligned with best practices." This collaborative effort promotes a transition towards more efficient and effective healthcare management.

Additional Engagements at the Conference

In addition to the main presentation, Dr. Naqi Khan, MCG's Vice President of Health AI Products, will partake in a panel discussion on "Data You Can Trust: AI, Interoperability, and the Race for a Unified Patient Record" on November 16. This panel will involve notable experts such as Andrew Cohen from IBM and Sara Zywicki from b.well Connected Health, who will explore how interoperability and reliable data play a pivotal role in healthcare innovation.

HLTH 2026 is not only a prime opportunity to witness the intersection of AI and healthcare but also a platform for interactive discussions that can shape the future of medical practices. Attendees will have a chance to engage directly with leaders in the field, gaining insights that could influence their approaches to healthcare delivery.

Conclusion

The collaboration between MCG Health and Telligen symbolizes a significant advancement in the use of AI within the healthcare industry. As professionals gather at HLTH 2026, the shared insights on AI-driven medical necessity reviews will undoubtedly encourage conversations about the future of healthcare. This conference represents an essential gathering for those interested in innovation, collaboration, and meaningful progress in healthcare practices.

For more information on HLTH 2026 and registration details, visit HLTH's official website.